4cku
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4cku' size='340' side='right' caption='[[4cku]], [[Resolution|resolution]] 1.85Å' scene=''> | <StructureSection load='4cku' size='340' side='right' caption='[[4cku]], [[Resolution|resolution]] 1.85Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4cku]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[4cku]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Plafa Plafa]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CKU OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CKU FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=P2F:5-[1,1-BIS(OXIDANYLIDENE)-1,2-THIAZINAN-2-YL]-N3-[(2S,3R)-4-[2-(3-METHOXYPHENYL)PROPAN-2-YLAMINO]-3-OXIDANYL-1-PHENYL-BUTAN-2-YL]-N1,N1-DIPROPYL-BENZENE-1,3-DICARBOXAMIDE'>P2F</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=P2F:5-[1,1-BIS(OXIDANYLIDENE)-1,2-THIAZINAN-2-YL]-N3-[(2S,3R)-4-[2-(3-METHOXYPHENYL)PROPAN-2-YLAMINO]-3-OXIDANYL-1-PHENYL-BUTAN-2-YL]-N1,N1-DIPROPYL-BENZENE-1,3-DICARBOXAMIDE'>P2F</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Plasmepsin_II Plasmepsin II], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.39 3.4.23.39] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Plasmepsin_II Plasmepsin II], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.39 3.4.23.39] </span></td></tr> | ||
| Line 17: | Line 17: | ||
</div> | </div> | ||
<div class="pdbe-citations 4cku" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4cku" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Plasmepsin|Plasmepsin]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Plafa]] | ||
[[Category: Plasmepsin II]] | [[Category: Plasmepsin II]] | ||
| - | [[Category: Plasmodium falciparum]] | ||
[[Category: Jaudzems, K]] | [[Category: Jaudzems, K]] | ||
[[Category: Leitans, J]] | [[Category: Leitans, J]] | ||
Revision as of 07:49, 17 January 2018
Three dimensional structure of plasmepsin II in complex with hydroxyethylamine-based inhibitor
| |||||||||||
Categories: Plafa | Plasmepsin II | Jaudzems, K | Leitans, J | Tars, K | Drug design | Hydrolase | Malaria
